Novartis Investigative Site

HUS Helsinki FIN-00029

0 studies enrolling now · 3 studies all time

What they study most

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Chronic Myelogenous Leukemia, Hypereosinophilic Syndrome, Multiple Myeloma, Myelogenous Leukemia, Chronic, Systemic Mastocytosis

Studies at this site

• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies — Completed
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed